DOH - Bicol: Watch our El Niño - related illnesses | Inquirer News

DOH – Bicol: Watch our El Niño – related illnesses

/ 08:37 PM February 21, 2024

el nino hot

 

NAGA CITYーCiting the Philippine Atmospheric, Geophysical and Astronomical Services (Pagasa) advisory, the Department of Health (DOH) Bicol regional office warned the public of the harmful effects of the prevailing El Niño phenomenon on Tuesday.

DOH – Bicol Center for Health Development advised the public to take precautions against diseases such as dengue, chikungunya, cholera, heat stroke, typhoid fever, paralytic shellfish poisoning, and leptospirosis amid the strong El Niño season.

Article continues after this advertisement

Recently, it was reported by the Bureau of Fisheries and Aquatic Resources that the coastal waters in the town of Milagros, Masbate are positive for paralytic shellfish poison along with other coastal areas of the country.

FEATURED STORIES

“Avoid eating shellfish, alamang, and small fish sourced from red tide-positive coastal water,” the DOH said in a statement.

The public was likewise advised to consult the nearest healthcare providers for health-related concerns due to the extreme heat.

Article continues after this advertisement

According to Pagasa, a strong and mature El Niño will continue through end of February and may persist until May 2024.(Maida Boaragay, INQUIRER intern)

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

TAGS: Bicol, DoH, El Niño, Health

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.